Here are relevant reports on : clinical-trial-imaging-market
-
Seismic Survey Market by Service (Data Acquisition (Land, Marine, and Air-Borne), Data Processing, and Interpretation), Technology (2D imaging, 3D imaging, and 4D imaging), and Region - Global Forecast to 2022
The global seismic survey market was USD 7.24 Billion in 2016 and is estimated to grow at a CAGR of 4.24%, from 2017 to 2022. The use of seismic technology in brownfields projects and shale gas exploration is expected to drive the market for seismic surveys. To provide an in-depth understanding of the competitive landscape, the report includes the profiles of companies such as Compagnie Generale de Geophysique (CGG) (France), Petroleum Geo-Services (PGS) (Norway), Fugro N.V. (Netherlands), Polarcus Limited (U.A.E.), Tomlinson Geophysical Services (TGS)-Norwegian Petroleum Exploration Consultants (NOPEC) Geophysical Company (Norway), SeaBird Exploration, PLC (Cyprus), Ion Geophysical Corporation (U.S.), Schlumberger Limited-WesternGeco (U.S.), Pulse Seismic, Inc. (Canada), and Global Geophysical Services, Inc. (U.S.).
- Published: June 2017
- Price: $ 4950
- TOC Available:
-
Europe eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (Pharma, Biotech, Medtech), Opportunities, Trends, Market Share - Forecast to 2030
The Europe eClinical solutions market, valued at US$2.82 billion in 2024, stood at US$3.18 billion in 2025 and is projected to advance at a resilient CAGR of 13.0% from 2025 to 2030, culminating in a forecasted valuation of US$5.86 billion by the end of the period. This growth is driven by the increasing shift toward digital and decentralized clinical trial models enabled by CTR and CTIS adoption.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Electronic Trial Master File (eTMF) Systems Market by Offering (Integrated, Standalone), Function (Analytic, Compliance, Workflow, Audit), Therapeutic (Onco, Cardio, Neuro), End User (Pharma, Biotech, MedDevice), Phase, Region - Global Forecast to 2030
The global electronic trial master file (eTMF) systems market, valued at US$1.21 billion in 2024, stood at US$1.36 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2024 to 2030, culminating in a forecasted valuation of US$2.49 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Biosimulation Market by Phase (Drug Discovery, Preclinical, Regulatory), Modality (Antibody, Peptide), Application (Molecular Design, PK/PD, QSP, Trial Simulation, Disease Modeling), Indication (Cardio, Onco), End User (CRO, Pharma) – Global Forecast to 2031
The global biosimulation market is projected to reach USD 9.24 billion by 2031, growing at a CAGR of 16.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
World Healthcare IT (Provider and Payor) Market - Clinical (EMR, PACS, RIS, CPOE, LIS) & Non-Clinical (RCM, Billing, Claims) Information systems Trends, opportunities & Forecast till 2015
The world healthcare IT market is expected to grow from $99.6 billion in 2010 to $162.2 billion in 2015, at a CAGR of 10.2% from 2010 to 2015. Need to cut healthcare costs, enhance clinical/administrative workflow of hospitals, and huge demand for faster, error-free, efficient healthcare delivery, is fueling the healthcare provider IT market worldwide. Furthermore, the initiatives taken by the government for adoption of healthcare IT systems globally are also a significant driving force. Some of the major initiatives expected to hugely impact the market are the U.S Healthcare reforms and ARRA incentives.
- Published: August 2011
- Price: $ 4950
- TOC Available:
-
Predictive Clinical Biomarkers Market by Product & Service (Consumable, Software), Technology (NGS, PCR), Disease (Cancer, Infectious), Application (Clinical Diagnostics)-Forecast to 2030
The predictive clinical biomarkers market, valued at US$7.84 billion in 2024, stood at US$8.49 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$14.69 billion by the end of the period. he market for predictive clinical biomarkers is growing rapidly as the healthcare industry shifts toward personalized and predictive medicine.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031
The Europe companion animal diagnostics market, valued at USD0.43 billion in 2025, stood at USD0.46 billion in 2026 and is projected to advance at a resilient CAGR of 8.6% from 2026 to 2031, culminating in a forecasted valuation of USD0.70 billion by the end of the period. The market for diagnostics of companion animals in Europe is experiencing fast growth owing to factors such as increased pet ownership, animal health awareness, and advanced veterinary care being more widely accepted and costly.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Coagulation Analyzer Market by Product (Clinical Laboratory Analyzers, Consumables, Reagents, Systems), Test (PT Test, APT Test, D-Dimer Test), Technology (Optical, Mechanical), End User (Hospitals, Clinical Laboratory) & Region - Global Forecast to 2030
Global coagulation analyzers market valued at $3516.0M in 2024, reached $3,770.9M in 2025, and is projected to grow at a robust 7.2% CAGR, hitting $5,335.9M by 2030. The market is experiencing steady growth, primarily driven by the increasing prevalence of blood clotting disorders such as hemophilia and deep vein thrombosis. As the global population ages and chronic illnesses become more common, the demand for quick and accurate diagnostic tools continues to rise.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Asia Pacific Healthcare IT Market by Solution [Clinical (EHR, PACs & VNA, Telehealth, CDSS, Medical Image), Nonclinical (Clinical Analytics, RCM, Interoperability), Service (Claim, Billing)], End User [Hospital, ASC, Pharmacy, Payer]-Forecast to 2030
The Asia Pacific Healthcare IT market, valued at USD 68.96 billion in 2024, stood at USD 80.69 billion in 2025 and is projected to advance at a resilient CAGR of 17.6% from 2025 to 2030, culminating in a forecasted valuation of USD 181.30 billion by the end of the period. The Asia Pacific healthcare IT market is growing steadily, driven by increasing healthcare digitalization, rising patient volumes, government initiatives to adopt health IT, and expanding use of cloud, AI, and analytics in the region.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
